Status:
COMPLETED
Preoperative Methylprednisolone in Endovascular Aortic Repair
Lead Sponsor:
Louise de la Motte
Conditions:
Abdominal Aortic Aneurysms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to attenuate the systemic inflammatory response after Endovascular repair of abdominal aortic aneurysms, by administration of a single preoperative dosage of Methylprednis...
Eligibility Criteria
Inclusion
- Elective endovascular repair of an asymptomatic abdominal aortic aneurysm.
- Informed signed consent
Exclusion
- Positive HIV status, positive hepatitis B or C status
- Immunoinflammatory disease - except topically treated skin disease and respiratory disease.
- Glaucoma
- Gastric or duodenal ulcer
- Systemic fungal infection
- Immunosuppressive treatment
- Current treatment for cancer
- Allergy towards contents of Solu-Medrol
- Alcohol consumption: Men \> 21 drinks and women \> 14 drinks weekly
- Pregnancy
- Lack of informed signed consent
- Patients where follow up is planned at other location than Rigshospitalet.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00989729
Start Date
October 1 2009
End Date
April 1 2013
Last Update
November 14 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Vascular Surgery, Rigshospitalet 3111
Copenhagen, Denmark, 2100